Main Article Content

Abstract

The pathogenic process following ischemia of heart and brain is responsible a toll of deaths world over. The radicals like superoxide, hydroxyl radical, alkoxy or lipoxy radical can induce a huge damage over cardiovascular system. Xanthine oxidase mediated production of superoxide radicals has been accepted mostly as the key step in production of oxy-radicals mediated myocardial damage. Allopurinol, a xanthine oxidase inhibitor and inhibitor of uric acid formation has been selected as one of the antioxidants in this study. Allopurinol showed decreased mortality in the test animals. It has also reduced the ST elevation in post- reperfusion stage. It has also attenuated the infarct size significantly (p<0.05) owing to its capability to prevent excess formation of oxyradicals. It has also been substantiated that not acutely but chronically administered xanthine oxidase inhibitors may have its more profound anti-oxidant effect.

Keywords

Reperfusion Allopurinol Antioxidant Xanthine oxidase

Article Details

How to Cite
Dr.Ambrish Kumar Gupta, Dr.NeetLakhani, Dr KunalBarua, Dr.GaurangPandey, Dr. Praveen Katiyar, & Dr AnkitaShukla. (2021). A study of role of allopurinol in prevention of ischemic myocardial injury in rabbits. International Journal of Research in Pharmacology & Pharmacotherapeutics, 6(4), 447-454. https://doi.org/10.61096/ijrpp.v6.iss4.2017.447-454

References

  1. [1]. Banka, N. Anand, I.S Chakravarti, R.N Sharma, P.L and Wahi P.L; Macroscopic measurements of experimental myocardial infarct size in rhesus monkey – A comparison of two methods. PGI bulletin; 15, 1981, 147-50.
  2. [2]. Chambers, X.E., Parks, D.A. and Patterson, G.; Xanthine oxidase as a source of free radical damage in myocardial ischemia. J. Mol Cell Cardiol; 17, 1985, 145-52.
  3. [3]. Downey J. M., Miura, T., Eddy, L.J., Chambers, D.E., Mellert, T., Herse, D.J. and Yellon, D.M.; Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J. Mol. Cell. Cardiol; 19(11), 1987, 1053-60.
  4. [4]. Fishbein, M.C., Meerbaum, S. Rit., J. Lando, U., Kenmastuse, K., Mercier, J.C., Coorday, E. and Ganz, W., Early phase acute myocardial infarct size quantification: Validation of the triphenyltetrazolium chloride tissue enzyme staining techniques. Am Heart; 101, 1981, 593-600.
  5. [5]. Hoshida ,Y. Junsuke, I. Masashi, N., Masatugu, H. Takenobu, K., Tsunehiko, K. and Michihiko, T,; NO synthase protects the heart against ischemia reperfusion injury in rabbits- Methods for surgical preparation of ischemia reperfusion injury in rabbits; Journal of Pharmacology and experimental therapeutics. (JPET); 274, 1995, 413-414.
  6. [6]. Kela, A.K., Prakasam, L., Reddy and Thombre, D.P.; A modified spectrophotometric assay of superoxide dismutase; Indian J. Biochem. Biophysics; 21, 1984, 130-132.
  7. [7]. Maxwell M.P., Hearse, D.J and Yellon. D.M.: Species variation in the coronary circulation during regional myocardial ischemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc. Res; 21, 1987, 737-746.
  8. [8]. Mc. Cord J.M.; Overview and outlook: Free radicals and myocardial ischemia; Free Radic. Biol. Med; 4(1), 1988, 9-14.